Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes

Thomas J. Hoerger; A Sinha; M Rajan; Thomas J. Hoerger; L Pogach

Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes

Sinha, A., Rajan, M., Hoerger, T., & Pogach, L. (2010). Costs and Consequences Associated With Newer Medications for Glycemic Control in Type 2 Diabetes. Diabetes Care, 33(4), 695-700.

Copy citation

Meet the Experts

View All Experts

Navigate to Thomas J. Hoerger

Thomas J. Hoerger

Recent Publications

Article

Treatment preferences among patients with mild-to-moderate atopic dermatitis

December 31, 2023

Article

Understanding how infection prevention influences nurses' task sequencing using a mixed-methods, simulation-based approach

December 01, 2023

Article

Consensus-based framework for evaluating data modernization initiatives

October 01, 2023

Article

∆8-THC-COOH cross-reactivity with cannabinoid immunoassay kits and interference in chromatographic testing methods

September 15, 2023

View All Publications